Clincosm LogoSign in Get a demo

relapsed or refractory acute myeloid leukemia

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed or Refractory Acute Myeloid Leukemia, Relapsed or Refractory Chronic Myelomonocytic Leukemia, Relapsed or Refractory

Recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia
  • +2 more
  • Duarte, California
  • +1 more
Mar 14, 2023

Relapsed or Refractory Acute Myeloid Leukemia Trial in Taiyuan (Selinexor, Homoharringtonine, Daunorubicin)

Recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia
  • Taiyuan, Shanxi, China
    Tao Wang
Feb 9, 2023

Relapsed or Refractory Multiple Myeloma, Relapsed or Refractory Acute Myeloid Leukemia Trial in Worldwide (AMG 176, Azacitidine,

Recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Relapsed or Refractory Acute Myeloid Leukemia
  • AMG 176
  • +2 more
  • Duarte, California
  • +23 more
Feb 9, 2022

Relapsed or Refractory Acute Myeloid Leukemia Trial in Duarte, Houston (AMG 330, Pembrolizumab)

Terminated
  • Relapsed or Refractory Acute Myeloid Leukemia
  • Duarte, California
  • +1 more
Dec 2, 2021

Relapsed or Refractory Acute Myeloid Leukemia Trial in Seoul (PHI-101)

Recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia
  • Seoul, Korea, Republic of
    Seoul National University Cancer Hospital
Apr 18, 2021

Relapsed or Refractory Acute Myeloid Leukemia Trial in France (Dexamethasone, Amsacrine, Cytarabine)

Recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia
  • Grenoble, France
  • +7 more
Jul 29, 2020

Relapsed or Refractory Acute Myeloid Leukemia Trial in Philadelphia (Autologous Anti-CD 123 CAR TCR/4-1BB-expressing

Terminated
  • Relapsed or Refractory Acute Myeloid Leukemia
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Oct 13, 2017

Relapsed or Refractory Acute Myeloid Leukemia, Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Trial (VS-4718)

Withdrawn
  • Relapsed or Refractory Acute Myeloid Leukemia
  • Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
  • (no location specified)
Jan 26, 2017